Form 4: NeuroPace Director Uri Geiger Acquires Stock Options
SEC Form 4 Filing
Director Uri Geiger acquired 17,774 stock options in NeuroPace Inc. on June 7, 2024, according to a Form 4 filing.
Summary
- Uri Geiger, a director of NeuroPace Inc., acquired 17,774 stock options on June 7, 2024.
- The options have an exercise price of $6.47.
- The options vest in twelve equal monthly installments.
- The Form 4 was filed on June 11, 2024.
- Uri Geiger has granted power of attorney to Rebecca Kuhn, Leah Akin, Mark Weeks, Jaime Chase, Noel Ripberger-Scheick and Brian Suzuki to execute and file Forms 3, 4, and 5 on his behalf.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition by a director. While insider confidence is generally positive, this is a routine filing.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 2024/03/14 | Date of Power of Attorney execution. |
| 2024/06/07 | Date of stock option transaction. |
| 2024/06/11 | Date Form 4 was filed. |
| 2034/06/06 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.